Bone marrow neoplastic

Bone marrow - neoplastic myeloid

AML not otherwise specified

AMKL M7



Last author update: 1 February 2013
Last staff update: 24 March 2022

Copyright: 2001-2023, PathologyOutlines.com, Inc.

PubMed Search: Acute megakaryoblastic leukemia AMKL M7

Page views in 2022: 2,922
Page views in 2023 to date: 215
Cite this page: Mihova D. AMKL M7. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/leukemiaM7.html. Accessed January 28th, 2023.
Definition / general
  • Acute megakaryoblastic leukemia (AMKL, M7)
  • Up to 10% of AML in children, 5% or less of adult AML (Orphanet (May 2004): Acute megakaryoblastic leukemia [Accessed 6 April 2018])
  • See also Myeloid leukemia associated with Down syndrome
  • Associated with marrow fibrosis due to megakaryoblast secretion of fibrogenic cytokines, which makes marrow aspiration difficult
  • In adults, median age 57 years, 59% have prior hematologic disorder or myelodysplastic syndrome (Blood 2006;107:880)
  • 19% had prior chemotherapy, classify now as AML-MRC (myelodysplasia related changes) or t-AML
  • Survival: poor, median overall survival is 6 months
  • Peripheral blood: often contains micromegakaryocytes and atypical platelets
  • Down Syndrome (DS): 150x increased risk of AML compared to non-Down children age 0 - 4 years; 70% are AML M7 compared to 3 - 6% in non-Down children
  • DS children ages 0 - 3 years: ALL vs AML risk is 1:1.2 compared to 4:1 for non-DS children
Clinical features
  • Thrombocytopenia, may have thrombocytosis, dysplastic features in neutrophils, erythroids, megakaryocytes and platelets
  • Infrequent hepatosplenomegaly
  • Associated with germ cell tumors in young boys
Diagnosis
  • WHO 2008: 20%+ blasts
  • 50%+ blasts of megakaryocytic lineage are present in bone marrow
  • Must exclude AML-MRC (myelodysplasia related changes), AML with t(1;22)(p13;q13); inv(3)(q21;q26.2); t(3;3)(q21;q26.2) and Down syndrome related
  • Megakaryocytic lineage is based on CD41+, CD61+ or positive platelet peroxidase reaction on EM
Case reports
Microscopic (histologic) description
  • Megakaryoblasts (often better morphology on biopsy than smear) are medium / large cells with blue vacuolated, agranular, eosinophilic cytoplasm containing fine granules, cytoplasmic projections (blebs and pseudopods) resembling platelets, irregular cytoplasmic borders and cytoplasmic zoning; may occur in clusters
  • Nuclei are round or slightly indented with finely reticular, dense chromatin and 1 - 3 nucleoli
  • Myelofibrosis or increased marrow reticulin is common; may also have small lymphoid-like blasts
Microscopic (histologic) images

AFIP images
Missing Image

Abundant cytoplasm

Missing Image

Promegakaryocytes and large blasts

Missing Image

Touch prep shows 3 blasts

Missing Image

Extensive infiltration by blasts


Missing Image

Marked proliferation of megakaryocytes

Missing Image Missing Image

Reticulin stain shows marked increase in reticulin fibers

Missing Image

PAS+



Images hosted on other servers:
Missing Image

Bone marrow
biopsy: extensive
infiltration
by blasts

Missing Image Missing Image Missing Image Missing Image

CD61 stain

Missing Image

CD34: red, podocalyxin: brown

Cytology images

Images hosted on other servers:
Missing Image Missing Image

FNA and CSF

Electron microscopy description
  • Megakaryoblasts have demarcation membranes and “bulls-eye” alpha granules with peroxidase activity in nuclear envelope and endoplasmic reticulum, but not in granules and Golgi complex
Differential diagnosis
Back to top
Image 01 Image 02